These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
697 related items for PubMed ID: 15569201
1. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. Stolier AJ, Fuhrman GM, Mauterer L, Bolton JS, Superneau DW. Breast J; 2004; 10(6):475-80. PubMed ID: 15569201 [Abstract] [Full Text] [Related]
6. Newly diagnosed breast cancer patients choose bilateral mastectomy over breast-conserving surgery when testing positive for a BRCA1/2 mutation. Stolier AJ, Corsetti RL. Am Surg; 2005 Dec; 71(12):1031-3. PubMed ID: 16447474 [Abstract] [Full Text] [Related]
7. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA, Hereditary Breast Cancer Clinical Study Group. J Clin Oncol; 2008 Mar 01; 26(7):1093-7. PubMed ID: 18195327 [Abstract] [Full Text] [Related]
8. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. J Clin Oncol; 2004 Mar 15; 22(6):1055-62. PubMed ID: 14981104 [Abstract] [Full Text] [Related]
10. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey. Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E. CMAJ; 2001 Apr 03; 164(7):1005-9. PubMed ID: 11314429 [Abstract] [Full Text] [Related]
11. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations. Casey MJ, Synder C, Bewtra C, Narod SA, Watson P, Lynch HT. Gynecol Oncol; 2005 May 03; 97(2):457-67. PubMed ID: 15863145 [Abstract] [Full Text] [Related]
12. Disparities in BRCA testing: when insurance coverage is not a barrier. Olaya W, Esquivel P, Wong JH, Morgan JW, Freeberg A, Roy-Chowdhury S, Lum SS. Am J Surg; 2009 Oct 03; 198(4):562-5. PubMed ID: 19800469 [Abstract] [Full Text] [Related]
13. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations. Schmeler KM, Sun CC, Bodurka DC, White KG, Soliman PT, Uyei AR, Erlichman JL, Arun BK, Daniels MS, Rimes SA, Peterson SK, Slomovitz BM, Milam MR, Gershenson DM, Lu KH. Obstet Gynecol; 2006 Sep 03; 108(3 Pt 1):515-20. PubMed ID: 16946209 [Abstract] [Full Text] [Related]
14. Prophylactic mastectomy in familial breast carcinoma. What do the pathologic findings learn us? Leunen K, Drijkoningen M, Neven P, Christiaens MR, Van Ongeval C, Legius E, Amant F, Berteloot P, Vergote I. Breast Cancer Res Treat; 2008 Jan 03; 107(1):79-86. PubMed ID: 17431765 [Abstract] [Full Text] [Related]